The results suggest that anti-SS-A/Ro antibodies, particularly anti-Ro52, are strongly associated with the development of CHB in neonatal lupus, emphasizing the need for further research on specific epitopes and mechanisms. Here, TRIM21 is linked to systemic lupus erythematosus.